These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2164194

  • 21. Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.
    Sculier JP, Lafitte JJ, Paesmans M, Thiriaux J, Alexopoulos CG, Baumöhl J, Schmerber J, Koumakis G, Florin MC, Zacharias C, Berghmans T, Mommen P, Ninane V, Klastersky J.
    Br J Cancer; 2000 Nov; 83(9):1128-35. PubMed ID: 11027424
    [Abstract] [Full Text] [Related]

  • 22. [Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
    Ohnoshi T, Hiraki S, Ueoka H, Tamura T, Kawahara S, Yonei T, Yamashita H, Ishii J, Tamai M, Egawa T.
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):115-9. PubMed ID: 2827585
    [Abstract] [Full Text] [Related]

  • 23. A randomized trial of mitomycin/ifosfamide/cisplatin preoperative chemotherapy plus surgery versus surgery alone in stage IIIA non-small cell lung cancer.
    Rosell R, Maestre J, Font A, Moreno I, Molina F, Milla A, Gómez-Codina J, Camps C.
    Semin Oncol; 1994 Jun; 21(3 Suppl 4):28-33. PubMed ID: 8209274
    [Abstract] [Full Text] [Related]

  • 24. [A pilot study of induction chemotherapy with cisplatin, mitomycin C and vindesine for stage III N2 non-small cell lung cancer].
    Nishiwaki Y, Nagai K, Kodama T, Nishiyama H, Hojo H, Matsumoto T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31 Suppl():203-11. PubMed ID: 8007467
    [Abstract] [Full Text] [Related]

  • 25. [Radio-chemotherapy combination in locally advanced, inoperable, non-small cell bronchial cancers].
    Mornex F.
    Rev Pneumol Clin; 2002 Nov; 58(5 Pt 2):3S37-41. PubMed ID: 12538934
    [No Abstract] [Full Text] [Related]

  • 26. Comparison of vindesine plus cisplatin or vindesine plus mitomycin in the treatment of advanced non-small cell lung cancer.
    Shinkai T, Saijo N, Tominaga K, Eguchi K, Shimizu E, Sasaki Y, Fujita J, Futami H.
    Cancer Treat Rep; 1985 Sep; 69(9):945-51. PubMed ID: 2992785
    [Abstract] [Full Text] [Related]

  • 27. [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
    Zhang X, Sun Y, Feng F.
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):220-3. PubMed ID: 11776842
    [Abstract] [Full Text] [Related]

  • 28. [Treatment of non-small cell cancer of the lung with a combination of cisplatin-VP-16 and mitomycin C].
    Arraztoa J, Orlandi L, Rodríguez R, Vogel C, Ramírez G.
    Rev Med Chil; 1987 Jan; 115(1):31-6. PubMed ID: 3039639
    [No Abstract] [Full Text] [Related]

  • 29. Docetaxel: new indication. First-line treatment of non small-cell lung cancer: no advance.
    Prescrire Int; 2005 Feb; 14(75):16-8. PubMed ID: 15751170
    [Abstract] [Full Text] [Related]

  • 30. Adjuvant chemotherapy in resected non-small cell lung cancer.
    Cangiano R.
    Rays; 2004 Feb; 29(4):435-7. PubMed ID: 15852732
    [Abstract] [Full Text] [Related]

  • 31. [Prospective randomized study of HMVP, MVP, and HVP regimens in treatment of advanced non-small cell lung cancer].
    Gao JF, Li CS, Zhang BC, Du GZ, Zhang XH, Wang J, Zhu YZ, Ou WL, Yang B.
    Ai Zheng; 2004 Apr; 23(4):435-8. PubMed ID: 15087034
    [Abstract] [Full Text] [Related]

  • 32. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
    Joss RA, Alberto P, Obrecht JP, Barrelet L, Holdener EE, Siegenthaler P, Goldhirsch A, Mermillod B, Cavalli F.
    Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
    [Abstract] [Full Text] [Related]

  • 33. Cisplatin and vindesine combination chemotherapy for non-small cell lung cancer: a randomized trial comparing two dosages of cisplatin.
    Shinkai T, Saijo N, Eguchi K, Sasaki Y, Tominaga K, Sakurai M, Suga J, Miyaoka H, Sano T, Keicho N.
    Jpn J Cancer Res; 1986 Aug; 77(8):782-9. PubMed ID: 3019976
    [Abstract] [Full Text] [Related]

  • 34. Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin.
    González Barón M, Artal A, Garrido P, García Girón C, Ordóñez A, Feliu J, Berrocal A, Barón JM.
    Am J Clin Oncol; 1993 Aug; 16(4):310-4. PubMed ID: 8392287
    [Abstract] [Full Text] [Related]

  • 35. A randomized trial in inoperable non-small-cell lung cancer: vindesine and cisplatin versus mitomycin, vindesine, and cisplatin versus etoposide and cisplatin alternating with vindesine and mitomycin.
    Fukuoka M, Masuda N, Furuse K, Negoro S, Takada M, Matsui K, Takifuji N, Kudoh S, Kawahara M, Ogawara M.
    J Clin Oncol; 1991 Apr; 9(4):606-13. PubMed ID: 1648597
    [Abstract] [Full Text] [Related]

  • 36. Random prospective study of vindesine versus vindesine plus high-dose cisplatin versus vindesine plus cisplatin plus mitomycin C in advanced non-small-cell lung cancer.
    Einhorn LH, Loehrer PJ, Williams SD, Meyers S, Gabrys T, Nattan SR, Woodburn R, Drasga R, Songer J, Fisher W.
    J Clin Oncol; 1986 Jul; 4(7):1037-43. PubMed ID: 3088219
    [Abstract] [Full Text] [Related]

  • 37. [Cisplatin-Vepeside versus Endoxan-Vepeside in the treatment of small cell bronchial cancer. A randomized study].
    Heckmayr M, Gatzemeier U, Hossfeld DK, Koschel G, Thies F, Zschaber R.
    Pneumologie; 1990 Feb; 44 Suppl 1():256-7. PubMed ID: 2164193
    [Abstract] [Full Text] [Related]

  • 38. [Advances in the treatment of non-small cell lung cancer].
    Sculier JP.
    Pathol Biol (Paris); 1992 Nov; 39(9):938-9. PubMed ID: 1311447
    [No Abstract] [Full Text] [Related]

  • 39. Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer.
    Kubota K, Furuse K, Kawahara M, Kodama N, Ogawara M, Takada M, Masuda N, Negoro S, Matsui K, Takifuji N, Kudoh S, Kusunoki Y, Fukuoka M.
    Cancer Chemother Pharmacol; 1997 Nov; 40(6):469-74. PubMed ID: 9332460
    [Abstract] [Full Text] [Related]

  • 40. [The relation between myelotoxicity and performance status or aging in chemotherapy of non-small cell lung cancer].
    Oshita F, Shinkai T, Miya T, Kojima A, Ohe Y, Tamura T, Sasaki Y, Eguchi K, Saijo N.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Feb; 29(2):231-8. PubMed ID: 1851904
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.